Drug Development – Page 7

Novo Holdings to Finalize $16.5B Acquisition of Catalent Following Regulatory Clearance

12 months ago talkbio0Tagged Acquisition, Catalent, Drug Development, Holdings, Life Sciences, regulatory

Novo Holdings, Catalent, Acquisition, Regulatory Clearance, Life Sciences, Pharmaceutical Development

Relmada Therapeutics Reassesses Strategy Following Discontinuation of Two Phase 3 Trials for REL-1017

1 year ago talkbio0Tagged Clinical Trials, Drug Development, MDD, Phase 3 trials, REL-1017, Relmada, Strategic Options, Unipolar Depression

Relmada Therapeutics, REL-1017, Phase 3 trials, Major Depressive Disorder (MDD), strategic options, clinical trials, drug development

Nabla Bio Revolutionizes AI-Driven Protein Design with $26M Series A Funding and Major Pharmaceutical Collaborations

1 year ago talkbio0Tagged Drug Development, Funding, Generative Protein Design, Multipass Membrane, Pharmaceutical Collaborations, Proteins, Series, Therapeutic Antibodies

Generative Protein Design, AI-Driven Drug Development, Therapeutic Antibodies, Multipass Membrane Proteins, Pharmaceutical Collaborations, Series A Funding

AstraZeneca Halts Development of Opioid Use Disorder Drug Due to Antifungal Interaction

1 year ago talkbio0Tagged Antifungal Agents, AstraZeneca, Clinical Trials, Drug Development, Opioid Use Disorder, Social Interaction

AstraZeneca, Opioid Use Disorder, Drug Development, Antifungal Interaction, Clinical Trials

Enveda Secures $130 Million in Funding for Innovative Therapies in Inflammation, Obesity, and Beyond

1 year ago talkbio0Tagged Drug Development, Enveda, I&I, Inflammation, Microsoft-backed, Obesity, Pharma

Enveda, Microsoft-backed, $130M funding, Inflammation & Immunology (I&I), obesity, biotech, pharma, drug development

Aizen Therapeutics Unveils AI-Driven ‘Mirror Peptide’ Platform to Revolutionize Drug Development

1 year ago talkbio0Tagged Aizen, Biologic Medicine, Caltech, Cancer Therapeutic Procedure, Drug Development, mirror peptides

Aizen Therapeutics, Caltech spinout, AI-driven platform, mirror peptides, drug development, biologic medicine, cancer treatment

Pfizer Expands Collaboration with Flagship Pioneering, Adding Ampersand Biomedicines and Montai Therapeutics

1 year ago talkbio0Tagged Ampersand, Biomedicines, Drug Development, Flagship, Montai, Non-Small Cell Lung Carcinoma, Obesity, Pfizer, Pioneering, strategic partnership

Pfizer, Flagship Pioneering, Ampersand Biomedicines, Montai Therapeutics, strategic partnership, drug development, obesity, non-small cell lung cancer